<DOC>
	<DOCNO>NCT00452686</DOCNO>
	<brief_summary>This study evaluate safety immunogenicity booster dose GSK Biologicals ' reduce antigen content diphtheria , tetanus , acellular pertussis ( dTpa ) vaccine - Boostrix comparison Chinese DT vaccine , child 6-8 year age .</brief_summary>
	<brief_title>Study Assess Safety &amp; Immunogenicity GSK Biologicals ' Boostrix ( dTpa ) Vaccine vs. Chinese DT Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>A male female , include , 68 year age time vaccination , Written inform consent obtain parent guardian subject , Subjects receive total 4 dos DTP vaccine first 2 year life , subject receive previous DTP booster vaccination since administration fourth dose vaccine second year life participate . Subjects history diphtheria , pertussis tetanus diseases participate .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Chinese DT vaccin</keyword>
</DOC>